| Company's Shares of Common Stock Reserved for Issuance |
The Company’s shares of common stock reserved for issuance as of the periods indicated were as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
April 2017 Warrants |
|
|
24,725 |
|
|
|
24,725 |
|
June 2017 Warrants |
|
|
41,736 |
|
|
|
41,736 |
|
December 2018 Warrants |
|
|
11,332 |
|
|
|
11,332 |
|
Pre-funded PIPE Warrants |
|
|
5,780,537 |
|
|
|
5,780,537 |
|
2021 Pre-funded Warrants |
|
|
32,175,172 |
|
|
|
32,175,172 |
|
2023 Pre-funded Warrants |
|
|
5,666,667 |
|
|
|
5,666,667 |
|
Stock options outstanding |
|
|
13,189,871 |
|
|
|
13,554,621 |
|
Issued and nonvested RSUs |
|
|
4,043,000 |
|
|
|
4,677,500 |
|
Total shares reserved |
|
|
60,933,040 |
|
|
|
61,932,290 |
|
|
| Summary of Outstanding Warrants for Company's Common Stock |
The following table summarizes the outstanding warrants for the Company’s common stock as of June 30, 2025:
|
|
|
|
|
|
|
|
|
Expiration Date |
|
Shares Underlying
Outstanding Warrants |
|
|
Exercise Price |
|
April 2027 |
|
|
24,725 |
|
|
$ |
2.87 |
|
June 2027 |
|
|
41,736 |
|
|
$ |
2.87 |
|
December 2028 |
|
|
11,332 |
|
|
$ |
2.87 |
|
None |
|
|
43,622,376 |
|
|
$ |
0.001 |
|
|
|
|
43,700,169 |
|
|
|
|
|
| Components of Accumulated Other Comprehensive Loss |
The components of accumulated other comprehensive loss as of the dates indicated and the change during the period were (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Translation Adjustment |
|
|
Unrealized Gain (Loss) on ST Investments |
|
|
Total Accumulated Other Comprehensive Loss |
|
Balance, December 31, 2023 |
|
$ |
(461 |
) |
|
$ |
190 |
|
|
$ |
(271 |
) |
Change |
|
$ |
(523 |
) |
|
$ |
44 |
|
|
$ |
(479 |
) |
Balance, December 31, 2024 |
|
$ |
(984 |
) |
|
$ |
234 |
|
|
$ |
(750 |
) |
Change |
|
$ |
774 |
|
|
$ |
(240 |
) |
|
$ |
534 |
|
Balance, June 30, 2025 |
|
$ |
(210 |
) |
|
$ |
(6 |
) |
|
$ |
(216 |
) |
|